It's part of a a new program called Imprimis Cares that will make over 7,800 FDA-approved generic drugs available at an affordable price.
A pharmaceutical company announced Thursday that it plans to introduce a significantly lower-cost version of Daraprim, the drug that made headlines last month after jumping from $13.50 per pill to $750.